Lack of funding prevents the emergence of more companies in the Novo Nordisk and Leo Pharma league

2023-11-03T15:05:24+01:00

The development of new drugs takes time, involves high risks, and requires substantial capital, especially when it involves innovative treatment modalities and/or new biological targets.